The Scientist

» clinical trials and developmental biology

Most Recent

image: Pharma Moves Toward Transparency

Pharma Moves Toward Transparency

By | July 29, 2013

The pharmaceutical industry has agreed to share data from clinical trials with researchers, patients, and the public.

0 Comments

image: First Ever iPS-Cell Trial a Go

First Ever iPS-Cell Trial a Go

By | July 22, 2013

The Japanese government will allow a study of stem cell therapy using patients’ own cells, reprogrammed to be stem cells, to treat vision loss.

1 Comment

image: Week in Review, July 15–19

Week in Review, July 15–19

By | July 19, 2013

Bias in preclinical research; medical marijuana for kids; a swath of microbial genomes; plastic ocean habitats; rethinking scientific evaluation

0 Comments

image: Misconduct Delayed Drug Approval

Misconduct Delayed Drug Approval

By | July 10, 2013

FDA endorsement of a new blood-thinning drug was held back for almost a year because the agency discovered misconduct at clinical trial sites in China.  

2 Comments

image: Worried Sick

Worried Sick

By | July 1, 2013

Expectations can make you ill. Fear can make you fragile. Understanding the nocebo effect may help prevent this painful phenomenon.

3 Comments

image: Week in Review, June 17–21

Week in Review, June 17–21

By | June 21, 2013

On the gene patent decision; a high-res human brain model; bats’ influence on moths mating calls; toxicants threaten brain health; platelet-driven immunity

0 Comments

image: Restoring Hidden Clinical Data

Restoring Hidden Clinical Data

By | June 18, 2013

Backed by two leading medical journals, researchers propose a new plan to publish clinical trial data that pharmaceutical companies often try to bury.  

0 Comments

image: Nailing Regeneration

Nailing Regeneration

By | June 12, 2013

Researchers identify the signaling program that enables finger and toenail stem cells to direct digit regeneration after amputation.

0 Comments

image: FDA Considers Easing Controls on Diabetes Drug

FDA Considers Easing Controls on Diabetes Drug

By | June 11, 2013

A panel of advisors says that the agency should loosen restrictions on the sale of a diabetes drug with a spotty clinical safety record.  

0 Comments

US watchdog suspends plans to discipline researchers who failed to disclose the full risks of an experimental trial conducted with premature infants.

1 Comment

Popular Now

  1. Scientists Activate Predatory Instinct in Mice
  2. Superbug Resistant to Every Antibiotic in the U.S. Killed Nevada Woman
  3. Next Generation: Mobile Microscope Detects DNA Sequences
  4. Tenure Under Attack in Two More States
    The Nutshell Tenure Under Attack in Two More States

    Proposed legislation would eliminate academic tenure at public universities in Iowa and Missouri, echoing a move that has already gutted such permanent posts in Wisconsin.

RayBiotech